FOXO1 and nasopharyngeal carcinoma: Li et al.36demonstrated that FOXO1 suppresses tumor stemness and epithelial-mesenchymal transition while inducing cisplatin sensitivity in NPC cells by downregulating MYH9 expression through the PI3K/AKT/c-Myc/P53/miR-133a-3p axis.